ELAVL1 and metabolic dysfunction-associated steatotic liver disease: Currently, no study has been conducted to evaluate the changes in HuR and in HuR-mediated modulation of oxidative stress in an MCD model of NAFLD, although the capability of HuR to modulate the antioxidant system in other organs is already known.